Westley Croup Score Calculator- Free Croup Severity Assessment Tool

About This Westley Croup Score Calculator

This free Westley Croup Score calculator is designed for healthcare providers, medical students, nursing staff, and caregivers seeking to objectively assess croup severity in children using the internationally validated five-component scoring system. The tool calculates a total score from 0 to 17 by summing points assigned to stridor, chest wall retractions, air entry, cyanosis, and level of consciousness — immediately classifying the result as mild (0-2), moderate (3-7), severe (8-11), or impending respiratory failure (12 and above).

The calculator applies the original Westley Croup Score methodology first described in the 1978 American Journal of Diseases of Children, validated globally across diverse paediatric populations and referenced in guidelines from the American Academy of Pediatrics, the Canadian Paediatric Society, the Australasian College for Emergency Medicine, and the Royal College of Paediatrics and Child Health. Clinical action guidance reflects current evidence-based recommendations for dexamethasone dosing (0.15-0.6 mg/kg by severity), nebulised epinephrine indications, observation periods post-epinephrine administration, and escalation criteria for hospital admission and intensive care involvement.

Three stacked visualization panels help interpret the score at a glance: the Risk Ladder highlights the active severity tier across four clinical levels; the Zone Bar with animated triangle marker shows where the total score falls along the full 0-17 severity spectrum with individual component contribution bars showing which clinical signs are driving the result; and the Radar Spider Chart plots all five component scores against their maximums to reveal the full clinical severity profile — whether severity is driven primarily by stridor and retractions, or whether the critical high-weight components (cyanosis, altered consciousness) are contributing.

Westley Croup Score Calculator: Complete Clinical Guide to Croup Severity Assessment and Management

Croup, or laryngotracheobronchitis, is one of the most common causes of acute upper airway obstruction in young children, responsible for approximately 15% of all paediatric respiratory illness presentations in emergency departments worldwide. The Westley Croup Score is the most widely validated and clinically utilised tool for objectively quantifying croup severity, guiding treatment decisions, and predicting which children require hospitalisation versus safe discharge home.

First described by Dr. Robert Westley and colleagues in 1978 during a landmark randomised controlled trial of nebulised racemic epinephrine, the scoring system was originally developed to standardise severity assessment across clinical research sites. Over the subsequent four decades, it has been adopted globally as the standard clinical instrument for croup evaluation, validated across diverse paediatric populations spanning North America, Europe, Australia, and Asia.

This comprehensive guide explores the clinical foundation of the Westley Croup Score, the physiological basis of each scored component, interpretation of results, evidence-based management thresholds, and the broader context of croup as a paediatric emergency. Healthcare providers, parents, and educators will find detailed explanations of how this scoring system translates clinical observations into actionable treatment pathways.

The History and Development of the Westley Croup Score

The clinical need for a standardised croup severity scale arose from the challenges facing paediatric researchers in the 1970s. Prior to the Westley score, croup severity was assessed using inconsistent qualitative descriptions — "mild," "moderate," or "severe" — with no agreed operational definitions. This made it impossible to compare outcomes across different institutions or to reliably assess treatment responses in clinical trials.

Westley and colleagues designed their scoring instrument specifically for use in a multicentre trial examining the efficacy of nebulised racemic epinephrine in croup. By assigning numerical values to five observable clinical signs — stridor, chest wall retractions, air entry, cyanosis, and consciousness — they created a reproducible instrument that field clinicians could apply consistently at the bedside.

The original 1978 publication in the American Journal of Diseases of Children demonstrated that the composite score was sensitive to clinically meaningful treatment responses, declining significantly in the epinephrine group compared to placebo. This validated the instrument's responsiveness, not just its reliability. Subsequent studies over the following decades confirmed its predictive validity for hospitalisation, need for intubation, and safe discharge criteria.

Today, the Westley score is embedded in clinical practice guidelines from the American Academy of Pediatrics (AAP), the Canadian Paediatric Society (CPS), the Australasian College for Emergency Medicine (ACEM), and the Royal College of Paediatrics and Child Health (RCPCH), as well as numerous national emergency medicine curricula worldwide.

Understanding Croup: Pathophysiology and Epidemiology

Croup is a clinical syndrome characterised by the triad of barky or seal-like cough, inspiratory stridor, and hoarseness, resulting from subglottic airway inflammation and oedema. The subglottic region — just below the vocal cords — is the narrowest fixed point of the paediatric upper airway, making it disproportionately sensitive to even small amounts of oedema. In young children, the subglottis may measure as little as 4mm in diameter; a 1mm circumferential reduction in radius reduces cross-sectional area by approximately 44% and increases airway resistance by a factor of 16, according to the Poiseuille equation.

Viral infection is responsible for the vast majority of croup cases. Parainfluenza virus type 1 accounts for roughly 75% of confirmed viral croup, with parainfluenza types 2 and 3, respiratory syncytial virus (RSV), influenza A and B, adenovirus, and rhinovirus responsible for the remainder. The virus infects the epithelial lining of the trachea and subglottis, triggering an inflammatory cascade that results in mucosal oedema, increased secretions, and submucosal infiltration with lymphocytes, histiocytes, and plasma cells.

Croup affects children primarily between the ages of 6 months and 6 years, with peak incidence between 1 and 2 years of age. Boys are affected approximately 1.4 times more frequently than girls, a pattern consistent across most published epidemiological series. Seasonal variation is pronounced in temperate climates, with parainfluenza type 1 causing biennial autumn epidemics in many regions. In the Northern Hemisphere, peak croup presentations typically occur from October through December.

The overall incidence of croup in children under 6 years is estimated at 3–6 cases per 100 child-years, making it the most common infectious cause of acute stridor in this age group. Approximately 85% of cases are mild and can be managed safely at home or with a single emergency department visit; fewer than 5% require hospitalisation, and intubation is needed in less than 1% of all cases.

Clinical Presentation and Natural History

Croup typically follows a recognisable prodromal phase of 12–72 hours characterised by low-grade fever, coryza, and mild pharyngitis, indistinguishable from a common viral upper respiratory infection. The characteristic barky cough and stridor then develop, often dramatically and typically at night — a pattern attributed to decreased circulating epinephrine levels and increased upper airway secretions in the supine position during sleep.

The natural history of croup is one of gradual resolution over 3–7 days in most cases. However, the first 24–48 hours represent the period of greatest risk, when airway oedema is most pronounced and deterioration can occur rapidly. Children with moderate-to-severe croup are at highest risk for respiratory failure during this window, making accurate severity assessment critical from the outset.

Recurrent croup — defined as three or more episodes of croup-like illness — warrants investigation for underlying anatomical abnormalities (subglottic stenosis, subglottic haemangioma), vocal cord pathology, or gastro-oesophageal reflux, which can mimic or exacerbate croup symptoms. Spasmodic croup, a non-infectious variant associated with atopy and airway hyperreactivity, tends to be milder and more abruptly self-resolving.

Westley Score Component 1: Stridor

Stridor is a high-pitched, monophonic respiratory sound produced by turbulent airflow through a narrowed upper airway. In croup, it is characteristically inspiratory or biphasic, reflecting dynamic narrowing at the subglottic level that worsens during the negative intrathoracic pressure of inspiration.

The Westley scoring system assigns stridor values based on the conditions under which it is present. A score of 0 indicates complete absence of stridor — the child's airway is not significantly compromised. A score of 1 is assigned when stridor is audible only when the child is agitated, crying, or active. This reflects borderline compromise: the resting airway maintains adequate patency, but the increased ventilatory demand of agitation unmasks the narrowing. A score of 2 indicates stridor audible at rest — a clinically significant finding suggesting ongoing significant airway compromise even in a calm, resting child.

The clinical importance of the at-rest versus agitation distinction cannot be overstated. Stridor at rest signifies that the resting airway diameter has been reduced to a point where normal tidal breathing generates sufficient turbulence to produce audible noise. This correlates strongly with other markers of severity and indicates a child who warrants close observation and likely pharmacological intervention.

It is important to distinguish stridor from stertor (snoring-like sounds originating in the nasopharynx) and from transmitted upper airway sounds from rhinorrhoea. True stridor in croup is best appreciated with a stethoscope at the neck overlying the trachea, and its quality — harsh, musical, or crowing — can help characterise its severity.

Westley Score Component 2: Retractions

Chest wall retractions represent the visible inward movement of compliant chest wall structures during inspiration as the respiratory muscles generate increased negative intrathoracic pressure to overcome increased airway resistance. In the context of upper airway obstruction, retractions are a direct sign of respiratory distress and compensatory effort.

Retractions are scored on a 0–3 scale in the Westley system. A score of 0 indicates no visible retractions. Score 1 (mild retractions) typically denotes subcostal or intercostal retractions alone — subtle inward movement visible between or below the ribs. Score 2 (moderate retractions) indicates more prominent retraction patterns, typically involving sternal or substernal retraction in addition to intercostal indrawing. Score 3 (severe retractions) describes marked, visible retractions at multiple sites — suprasternal, supraclavicular, intercostal, substernal, and subcostal simultaneously — reflecting extreme respiratory effort and impending fatigue.

The anatomical basis for retractions in young children reflects the high compliance of the paediatric rib cage. Unlike adults, whose more calcified and rigid thorax resists deformation under increased respiratory effort, the cartilaginous paediatric chest wall readily draws inward when significant negative intrathoracic pressures are generated. This property means that retractions in young children are a more sensitive marker of respiratory distress than in older patients, but must also be interpreted in the context of the child's age and chest wall compliance.

Westley Score Component 3: Air Entry

Air entry assessment reflects the adequacy of gas movement into the distal airways and alveoli, and is evaluated by auscultation of the lung fields. In croup, reduced air entry results from decreased tidal volume secondary to airway obstruction — the child is working hard but unable to move adequate volumes of air into the lungs with each breath.

Normal air entry (score 0) is characterised by clear, bilateral breath sounds of appropriate intensity. Mildly decreased air entry (score 1) indicates breath sounds that are audible but reduced in intensity, suggesting some limitation in tidal volume. Markedly decreased air entry (score 2) represents a clinically critical finding — nearly absent or very faint breath sounds despite visible respiratory effort, indicating severe airway compromise and inadequate ventilation.

The combination of increasing retractions with decreasing air entry is particularly alarming, indicating that the child's compensatory respiratory effort is no longer able to maintain adequate ventilation. This pattern — increasing work with decreasing effectiveness — represents impending respiratory failure and demands immediate intervention. Clinicians must be attentive to the child who appears to be "working hard but not moving air," as this pattern may precede abrupt decompensation.

Westley Score Component 4: Cyanosis

Cyanosis — the blue discolouration of skin and mucous membranes due to elevated deoxygenated haemoglobin — represents a late and serious sign of hypoxaemia in croup. Its presence indicates that airway obstruction has progressed to the point of impairing oxygenation, a pre-terminal finding in the natural history of severe croup.

The Westley scoring system reflects the clinical gravity of cyanosis with a disproportionately high point allocation: 4 points for cyanosis present only with agitation, and 5 points for cyanosis at rest. This weighting reflects the fact that any degree of cyanosis in croup is a serious finding warranting urgent intervention, and that cyanosis at rest represents impending respiratory failure.

It is essential to recognise that cyanosis is a relatively insensitive marker of hypoxaemia. Clinical cyanosis typically becomes visible only when oxygen saturation falls below approximately 85–90% — a level of hypoxaemia that may have caused significant physiological stress before becoming apparent to inspection. In the modern clinical environment, pulse oximetry is used to detect hypoxaemia long before cyanosis develops, making this component of the Westley score less commonly scored in settings with reliable oximetry equipment.

Clinicians should be aware that cyanosis is more difficult to detect in children with darker skin tones, where examination of mucous membranes (lips, buccal mucosa, tongue) and nail beds is more reliable than inspection of skin. In current practice, an oxygen saturation below 92–95% on pulse oximetry in a child with croup is the practical correlate of the cyanosis criterion and should prompt equivalent concern.

Westley Score Component 5: Level of Consciousness

Altered level of consciousness in croup — assigned the maximum single-component score of 5 points — is the most alarming clinical sign and represents a medical emergency demanding immediate airway intervention. Normal consciousness is assigned 0 points; any alteration receives 5 points.

Consciousness alterations in croup result from hypoxia, hypercapnia, or both. As airway obstruction progresses and ventilation fails, arterial oxygen tension falls and carbon dioxide accumulates. Hypercapnia causes cortical depression, initially manifesting as irritability or agitation (which can be mistaken for behavioural distress), followed by lethargy, obtundation, and ultimately unconsciousness.

A key clinical challenge is distinguishing normal childhood anxiety and distress — which are universal in young children presenting to medical settings — from true hypoxic or hypercapnic agitation. The agitated child with croup who has normal consciousness typically remains consolable by a caregiver, maintains eye contact, and responds appropriately to voice. The child with altered consciousness due to respiratory compromise may appear paradoxically "quiet" (due to fatigue or obtundation) but is unresponsive, does not maintain eye contact, or has lost awareness of their surroundings.

A child with croup who was previously agitated but suddenly becomes calm and still should be assessed immediately for respiratory fatigue rather than assumed to be improving. This "ominous calm" pattern represents exhaustion rather than recovery and often precedes cardiorespiratory arrest.

Evidence-Based Management by Severity

The Westley Croup Score provides the clinical framework that links severity assessment to treatment decisions, supported by robust randomised controlled trial evidence and international guideline consensus.

Mild Croup (Score 0-2): The cornerstone of management is dexamethasone, a long-acting systemic corticosteroid with proven efficacy in reducing the duration and severity of croup symptoms. A single oral dose of dexamethasone 0.15–0.6 mg/kg (maximum 10–16 mg depending on institutional protocol) has been shown in multiple meta-analyses to reduce return visits, hospitalisation rates, and symptom duration. Oral administration is as effective as intramuscular injection and significantly more acceptable to young children. Children with mild croup can typically be discharged home with appropriate caregiver education and written return precautions.

Moderate Croup (Score 3-7): Dexamethasone remains the primary treatment, typically at the higher dose range (0.3–0.6 mg/kg). Nebulised epinephrine (adrenaline) — either racemic epinephrine (2.25% solution, 0.5 mL in 3 mL saline) or L-epinephrine (5 mL of 1:1000 solution) — is considered when symptoms are moderate-to-severe, as it provides rapid (within 10–30 minutes) but temporary (2–3 hours) relief of airway oedema through alpha-adrenergic vasoconstriction of the submucosal vasculature. Children receiving nebulised epinephrine must be observed for a minimum of 3–4 hours after administration to monitor for symptom rebound, as the vasoconstrictive effect dissipates before the underlying inflammatory process resolves.

Severe Croup (Score 8+) and Impending Failure (Score 12+): These children require immediate assessment by the most senior available clinician, involvement of paediatric intensive care and anaesthesiology teams, and preparation for potential airway intervention. High-flow oxygen should be administered while maintaining the child's preferred position of comfort (typically held by a parent). Nebulised epinephrine should be administered without delay. The decision to intubate must be made proactively — before complete respiratory failure — in a controlled environment with appropriately skilled personnel. Emergency intubation in a fully arrested child with croup carries significantly higher risk of failed intubation and complications than planned intubation performed by a paediatric airway expert in an operating theatre or resuscitation bay.

Corticosteroids: The Evidence Base

The evidence supporting corticosteroid treatment in croup is among the most robust in paediatric emergency medicine. A 2004 Cochrane systematic review and subsequent updates have consistently demonstrated that systemic corticosteroids reduce the Westley Croup Score at 6 and 12 hours, reduce the need for adrenaline nebulisations, reduce hospitalisation rates, reduce the length of emergency department stay, and reduce the rate of return visits.

Dexamethasone has largely supplanted other corticosteroids in clinical practice due to its prolonged half-life (36–72 hours), strong anti-inflammatory potency, and availability for oral administration. The optimal dose remains a subject of ongoing research. Landmark trials have demonstrated equivalence between 0.15 mg/kg and 0.3 mg/kg in mild croup, while many guidelines recommend 0.6 mg/kg for moderate-to-severe disease. Prednisolone (1 mg/kg) is an acceptable alternative when dexamethasone is unavailable.

Nebulised budesonide (2 mg via nebuliser) is an alternative corticosteroid route with demonstrated efficacy in reducing croup severity scores, most useful in children who cannot tolerate oral medication. However, it is significantly more expensive, requires specialised nebulisation equipment, and has not consistently shown superiority to oral dexamethasone in head-to-head trials.

Nebulised Epinephrine: Mechanism and Clinical Use

Epinephrine (adrenaline) exerts its beneficial effect in croup primarily through alpha-adrenergic receptor-mediated vasoconstriction of the submucosal blood vessels in the upper airway. This rapidly reduces mucosal oedema, decreasing the effective airway resistance and improving airflow. The beta-adrenergic effects of epinephrine (bronchodilation) provide additional benefit in the lower airways.

The onset of action of nebulised epinephrine in croup is rapid — typically within 10–30 minutes — and the peak effect is seen at 30–60 minutes. The duration of action is 2–3 hours, after which symptoms may return to their pre-treatment level (rebound effect) as epinephrine is metabolised and the underlying mucosal oedema returns. This rebound phenomenon is the rationale for mandatory observation periods following epinephrine administration.

Multiple randomised trials have demonstrated equivalent efficacy between racemic epinephrine (a 50:50 mixture of L- and D-epinephrine isomers) and standard L-epinephrine (adrenaline). L-epinephrine administered at 5 mL of 1:1000 solution via nebuliser is now the preferred formulation in most health systems outside of North America, where racemic epinephrine has historically been the standard preparation.

Heliox and Other Adjunct Therapies

Heliox — a mixture of helium and oxygen (typically 70:30 or 80:20) — has been proposed as an adjunct treatment in severe croup based on its lower density compared to air-oxygen mixtures, which reduces turbulent airflow and decreases the work of breathing in upper airway obstruction. A Cochrane review has found insufficient evidence to recommend routine heliox use in croup, citing small sample sizes and methodological heterogeneity across available trials. It may be considered as a temporising measure in severe cases while awaiting definitive airway management.

Humidified air or mist therapy — historically a cornerstone of traditional croup management and the basis of the recommendation to "sit in a steamy bathroom" — has not been supported by randomised controlled evidence. Two well-designed trials found no difference in croup severity scores between children treated with humidified air versus dry air, leading to the abandonment of routine mist therapy in most contemporary guidelines.

Differential Diagnosis and When to Reconsider the Diagnosis

While croup is the most common cause of acute stridor in children between 6 months and 6 years, several dangerous alternative diagnoses must be considered, particularly in children who are rapidly deteriorating, have atypical features, or do not respond appropriately to standard croup treatment.

Epiglottitis — supraglottic infection characterised by rapid-onset high fever, drooling, dysphagia, muffled voice, and the "tripod" position — was historically caused by Haemophilus influenzae type b and was dramatically reduced following widespread HiB vaccination. However, it can still occur due to other organisms (Streptococcus species, Staphylococcus aureus, non-typeable Haemophilus) and in unimmunised individuals. Epiglottitis is a medical emergency in which direct laryngoscopy should be performed only in a controlled setting with surgical airway backup immediately available.

Bacterial tracheitis (pseudomembranous croup) is caused primarily by Staphylococcus aureus and produces a clinical picture initially resembling croup but with a more toxic appearance, higher fever, and rapid progression. Children with bacterial tracheitis typically do not respond to nebulised epinephrine and have a fulminant course requiring intubation and intravenous antibiotics.

Foreign body aspiration should be considered in any child with sudden onset stridor, particularly if there is no prodromal viral illness or if the stridor is unilateral or associated with asymmetric breath sounds. Retropharyngeal or peritonsillar abscesses, subglottic haemangioma, and congenital subglottic stenosis are additional entities to consider in appropriate clinical contexts.

Score Validation Across Diverse Populations

The Westley Croup Score has been validated in multiple independent cohorts since its original development. A 2001 validation study by Klassen and colleagues demonstrated strong inter-rater reliability (kappa 0.89) among emergency physicians and nurses using the score, confirming its reproducibility across different clinical observers. Studies from Australia, New Zealand, the United Kingdom, Canada, the Netherlands, and multiple Asian centres have confirmed its applicability across diverse ethnic and clinical populations.

Importantly, the score has been shown to be responsive to treatment — declining measurably following corticosteroid and epinephrine administration — validating its use not only for initial triage but also for monitoring treatment response over time. A reduction of 2 or more points following treatment has been proposed as a clinically meaningful response threshold, though this specific cut-off requires further validation across diverse settings.

Some studies have noted that the cyanosis and consciousness components are rarely scored in contemporary emergency departments equipped with continuous pulse oximetry, as these signs represent late-stage findings that are typically preempted by earlier clinical recognition and intervention. This has led to proposals for simplified versions of the score in research contexts, though the full 5-component Westley score remains the standard for clinical and research use.

Limitations of the Westley Croup Score

No clinical scoring tool is without limitations, and clinicians must understand the boundaries of the Westley Croup Score's applicability. The score is designed for the assessment of croup specifically and should not be applied to other causes of stridor or respiratory distress without careful clinical context.

The score relies on observation of clinical signs that are inherently dynamic — a child who is calm during assessment may have had recent agitation-related stridor, and a child who is crying during examination will appear to have more significant retractions than when at rest. Best practice is to assess the child while calm and held by a caregiver whenever possible, and to repeat assessments over time to capture the trajectory of illness.

The inter-rater reliability of clinical sign assessment varies among healthcare providers with different levels of training and experience. Retractions, in particular, can be variably interpreted between observers. Training and clinical experience remain essential complements to formal scoring systems.

The score was developed and validated primarily in emergency department and inpatient paediatric settings with continuous monitoring capability. Its application in pre-hospital or resource-limited settings requires additional contextualisation, as some management options (nebulised epinephrine, pulse oximetry, inpatient observation) may not be available.

Parental Education and Home Management

Given that the vast majority of croup episodes are mild and managed in the outpatient setting, caregiver education is a critical component of appropriate croup management. Parents and guardians should understand the natural history of croup, the role of prescribed treatments, and clear criteria for seeking urgent medical care.

Key elements of caregiver education include: reassurance that most croup resolves within 3–7 days; explanation of the role of single-dose dexamethasone in accelerating recovery; advice to keep the child calm, as agitation worsens symptoms; guidance to allow the child to adopt a comfortable position (usually sitting upright or held by a caregiver); and clear written return precautions. The recommendation to sit in a steamy bathroom, while a traditional home remedy, lacks evidence of efficacy but is not harmful if it provides comfort.

A commonly asked question is whether cool night air provides symptomatic relief. There is some observational evidence and physiological plausibility for cool, humidified air reducing airway mucosal oedema through vasoconstriction, and the phenomenon of children improving en route to hospital (exposed to cool night air) has been noted clinically. However, randomised trial evidence is lacking, and this intervention should not delay medical evaluation in significantly symptomatic children.

Special Populations and Considerations

Infants under 6 months of age presenting with croup-like symptoms warrant heightened concern, as this age group is not typical for viral croup and alternative diagnoses (subglottic haemangioma, laryngomalacia, congenital anomalies) must be excluded. Any infant under 3 months with stridor should be referred for formal airway evaluation.

Children with pre-existing upper airway conditions — including prior intubation, known subglottic stenosis, or previous difficult airway — are at significantly higher risk of severe complications with even mild degrees of additional inflammation. These children may deteriorate rapidly and should have a lower threshold for hospitalisation and specialist airway assessment.

Immunocompromised children (oncology patients, solid organ transplant recipients, children on immunosuppressive therapy) are at risk of atypical croup presentations with unusual organisms and may have blunted inflammatory responses that mask severity. Close liaison with the relevant specialist team is essential in these cases.

Integration with Modern Emergency Department Practice

In contemporary emergency departments, the Westley Croup Score is typically used alongside objective measurements including pulse oximetry, respiratory rate, and heart rate, rather than as a standalone tool. A child with a Westley score of 3–4 but with an oxygen saturation of 90% on room air should be treated with greater urgency than the score alone suggests, as hypoxaemia represents a critical physiological derangement regardless of observed signs.

Point-of-care ultrasound has been investigated as a potential adjunct to clinical croup assessment, with the subglottic diameter measurable on tracheal ultrasound. However, this technique remains investigational and has not been incorporated into routine scoring protocols. Neck X-ray showing the classical "steeple sign" (subglottic narrowing on anteroposterior view) may support the diagnosis but is neither sensitive nor specific for croup and is not required for clinical management in straightforward presentations.

Frequently Asked Questions